Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alván

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Progress in Clinical and Biological Research|January 1, 1986
Ethnic differences in reactions to drugs and xenobiotics. Other protein variants with pharmacogenetic consequences: albumin and orosomucoidG Alván
Lakartidningen|May 14, 1980
[Drug information centre--a new form of medical service in the Stockholm county]G Alván
Lakartidningen|June 25, 1999
[Quinine/quinidine treatment of cramps of the calf is not supported by the Pharmaceutical Product Agency]G Alván
Fundamental & Clinical Pharmacology|January 1, 1991
Clinical consequences of polymorphic drug oxidationG Alván
Lakartidningen|February 25, 1976
[Ibuprofen (Brufen) and naproxen (Naprosyn)]G Alván
Journal of Internal Medicine|June 1, 1992
Genetic polymorphisms in drug metabolismG Alván
European Journal of Clinical Pharmacology|December 22, 1998
The progress of COST B1--a European collaboration on the study of interindividual differences in drug disposition and action. Organization for European Co-operation in the field of Science and Technical ResearchP Bechtel, G Alván
Scandinavian Journal of Rheumatology|January 1, 1989
Debrisoquine hydroxylation phenotype in SLE patientsP Seideman, G Alván
European Journal of Clinical Pharmacology|January 1, 1994
Nonlinear kinetics of nortriptyline in relation to nortriptyline clearance as observed during therapeutic drug monitoringM Jerling, G Alván
Lakartidningen|March 29, 1971
[Treatment of acute poisoning. 3. Pharmacokinetic treatment principals]G Alván, F Sjöqvist
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Progress in Clinical and Biological Research|January 1, 1986
Ethnic differences in reactions to drugs and xenobiotics. Other protein variants with pharmacogenetic consequences: albumin and orosomucoidG Alván
Lakartidningen|May 14, 1980
[Drug information centre--a new form of medical service in the Stockholm county]G Alván
Lakartidningen|June 25, 1999
[Quinine/quinidine treatment of cramps of the calf is not supported by the Pharmaceutical Product Agency]G Alván
Fundamental & Clinical Pharmacology|January 1, 1991
Clinical consequences of polymorphic drug oxidationG Alván
Lakartidningen|February 25, 1976
[Ibuprofen (Brufen) and naproxen (Naprosyn)]G Alván
Journal of Internal Medicine|June 1, 1992
Genetic polymorphisms in drug metabolismG Alván
European Journal of Clinical Pharmacology|December 22, 1998
The progress of COST B1--a European collaboration on the study of interindividual differences in drug disposition and action. Organization for European Co-operation in the field of Science and Technical ResearchP Bechtel, G Alván
Scandinavian Journal of Rheumatology|January 1, 1989
Debrisoquine hydroxylation phenotype in SLE patientsP Seideman, G Alván
European Journal of Clinical Pharmacology|January 1, 1994
Nonlinear kinetics of nortriptyline in relation to nortriptyline clearance as observed during therapeutic drug monitoringM Jerling, G Alván
Lakartidningen|March 29, 1971
[Treatment of acute poisoning. 3. Pharmacokinetic treatment principals]G Alván, F Sjöqvist
Pageof 13